Clinical trial

Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or…

NCT00072280 · Children's Oncology Group, Other · Terminated

Key facts

NCT number NCT00072280
Title Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
Official title A Pilot Phase II Study for Children With Infantile Fibrosarcoma
Lead sponsor Children's Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH
Status Terminated
Phase Phase 2
Study type Interventional
Conditions Sarcoma
Intervention type Biological, Drug, Procedure
Interventions dactinomycin, cyclophosphamide, etoposide, ifosfamide, vincristine sulfate, Conventional Surgery, MESNA (mercaptoethane sulfonate), Filgrastim
Enrollment 7
Start date Nov 1, 2004
Primary completion Mar 1, 2008
Completion Mar 1, 2008
First posted Nov 6, 2003
Last update posted Sep 30, 2014
Countries Australia, Canada, New Zealand, United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies